These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26459026)

  • 1. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
    Toivo TM; Mikkola JA; Laine K; Airaksinen M
    Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-Drug Interactions and Their Association with Adverse Health Outcomes in the Older Community-Dwelling Population: A Prospective Cohort Study.
    Hughes JE; Bennett KE; Cahir C
    Clin Drug Investig; 2024 Jun; 44(6):439-453. PubMed ID: 38878216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of clinically manifested drug interactions in hospitalized patients: A systematic review and meta-analysis.
    Gonzaga de Andrade Santos TN; Mendonça da Cruz Macieira G; Cardoso Sodré Alves BM; Onozato T; Cunha Cardoso G; Ferreira Nascimento MT; Saquete Martins-Filho PR; Pereira de Lyra D; Oliveira Filho AD
    PLoS One; 2020; 15(7):e0235353. PubMed ID: 32609783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and management of clinically relevant drug-drug interactions with direct oral anticoagulants: an intervention study in community pharmacies.
    Capiau A; Mehuys E; Grymonprez M; Van Tongelen I; Christiaens T; Tommelein E; Philippe G; Lahousse L; De Backer T; Boussery K
    Thromb Res; 2024 Jun; 238():223-231. PubMed ID: 38733695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of natural health product adverse reactions (SONAR): active surveillance of adverse events following concurrent natural health product and prescription drug use in community pharmacies.
    Vohra S; Cvijovic K; Boon H; Foster BC; Jaeger W; LeGatt D; Cembrowski G; Murty M; Tsuyuki RT; Barnes J; Charrois TL; Arnason JT; Necyk C; Ware M; Rosychuk RJ
    PLoS One; 2012; 7(9):e45196. PubMed ID: 23028841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sharing Adverse Drug Event Reports Between Hospitals and Community Pharmacists to Inform Re-dispensing: An Analysis of Reports and Process Outcomes.
    Cragg A; Small SS; Lau E; Rowe A; Lau A; Butcher K; Hohl CM
    Drug Saf; 2023 Nov; 46(11):1161-1172. PubMed ID: 37783974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustainability challenges concerning the effects of high-priced drugs on the day-to-day operations of community pharmacies in Finland.
    Rosenberg S; Södergård B; Rosenholm J; Rauha JP
    Eur J Pharm Sci; 2024 Aug; 199():106816. PubMed ID: 38821247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and analysis of drug-drug interactions among hospitalized cardiac patients in the Mohammed V Military Teaching Hospital in Morocco.
    Fettah H; Moutaouakkil Y; Sefrioui MR; Moukafih B; Bousliman Y; Bennana A; Lamsaouri J; Makram S; Cherrah Y
    Pan Afr Med J; 2018; 29():225. PubMed ID: 30100979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polypharmacy, drug-drug interactions, and adverse drug reactions among systemic sclerosis patients: A cross-sectional risk factor study.
    Boukhlal S; Chouchana L; Saadi M; Casadevall M; Cohen P; Dunogue B; Murarasu A; Regent A; Mouthon L; Chaigne B
    Semin Arthritis Rheum; 2024 Aug; 67():152469. PubMed ID: 38781783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug use survey to identify significant drug-drug interactions and assess clinical importance in the outpatient setting of a tertiary care hospital.
    Chowdhury K; Hazra A; Ghosh S; Choudhury S
    Indian J Pharmacol; 2024 May; 56(3):172-177. PubMed ID: 39078180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pharmacovigilance study of pharmacokinetic drug interactions using a translational informatics discovery approach.
    Wang L; Shendre A; Chiang CW; Cao W; Ning X; Zhang P; Zhang P; Li L
    Br J Clin Pharmacol; 2022 Feb; 88(4):1471-1481. PubMed ID: 33543792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of CYP3A4-related potential drug-drug interactions in outpatients receiving prescriptions from multiple clinical departments.
    Matsuoka R; Akagi S; Konishi T; Kondo M; Matsubara H; Yamamoto S; Izushi K; Tasaka Y
    J Pharm Health Care Sci; 2024 Aug; 10(1):48. PubMed ID: 39103904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-drug interactions and the risk of adverse drug reaction-related hospital admissions in the older population.
    Hughes JE; Moriarty F; Bennett KE; Cahir C
    Br J Clin Pharmacol; 2024 Apr; 90(4):959-975. PubMed ID: 37984336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospital Pharmacists' Perceptions and Decision-Making Related to Drug-Drug Interactions.
    Bagri H; Dahri K; Legal M
    Can J Hosp Pharm; 2019; 72(4):288-294. PubMed ID: 31452540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive task analysis of clinicians' drug-drug interaction management during patient care and implications for alert design.
    Russ-Jara AL; Elkhadragy N; Arthur KJ; DiIulio JB; Militello LG; Ifeachor AP; Glassman PA; Zillich AJ; Weiner M
    BMJ Open; 2023 Dec; 13(12):e075512. PubMed ID: 38040422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-Drug Interactions and Actual Harm to Hospitalized Patients: A Multicentre Study Examining the Prevalence Pre- and Post-Electronic Medication System Implementation.
    Li L; Baker J; Quirk R; Deidun D; Moran M; Salem AA; Aryal N; Van Dort BA; Zheng WY; Hargreaves A; Doherty P; Hilmer SN; Day RO; Westbrook JI; Baysari MT
    Drug Saf; 2024 Jun; 47(6):557-569. PubMed ID: 38478349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug events caused by three high-risk drug-drug interactions in patients admitted to intensive care units: A multicentre retrospective observational study.
    Klopotowska JE; Leopold JH; Bakker T; Yasrebi-de Kom I; Engelaer FM; de Jonge E; Haspels-Hogervorst EK; van den Bergh WM; Renes MH; Jong BT; Kieft H; Wieringa A; Hendriks S; Lau C; van Bree SHW; Lammers HJW; Wierenga PC; Bosman RJ; de Jong VM; Slijkhuis M; Franssen EJF; Vermeijden WJ; Masselink J; Purmer IM; Bosma LE; Hoeksema M; Wesselink E; de Lange DW; de Keizer NF; Dongelmans DA; Abu-Hanna A
    Br J Clin Pharmacol; 2024 Jan; 90(1):164-175. PubMed ID: 37567767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective cohort observation on psychotropic drug-drug interaction and identification utility from 3 databases: Drugs.com®, Lexicomp®, and Epocrates®.
    Pinkoh R; Rodsiri R; Wainipitapong S
    PLoS One; 2023; 18(6):e0287575. PubMed ID: 37347788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential drug-drug interactions of frequently prescribed medications in long COVID detected by two electronic databases.
    Meakleartmongkol T; Tangpanithandee S; Vanavivit N; Jiso A; Pongchaikul P; Kirdlarp S; Khemawoot P; Nathisuwan S
    PLoS One; 2023; 18(11):e0293866. PubMed ID: 37972000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and factors associated with potential drug-drug interactions in prescriptions presented at private pharmacies in Mbarara city, southwestern Uganda.
    Lule AP; Delic OB; Katunguka K; Muwonge F; Yadesa TM
    BMC Pharmacol Toxicol; 2024 Jan; 25(1):2. PubMed ID: 38167526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.